Therapeutic Effect of Microfragmented Adipose Tissue (Lipogems) Injection on Maximum Interincisal Opening Versus Injectable Platelet-rich Plasma (PRP) for the Treatment of Anterior Disc Displacement With Reduction : A Randomized Clinical Trial

NCT ID: NCT07107399

Last Updated: 2025-08-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

PHASE2/PHASE3

Total Enrollment

16 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-08-05

Study Completion Date

2025-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

this procedure is to remove inflammatory mediators, reduce friction, stimulate the production of new synovial fluid, eliminate suction-cup effect.

The purpose of this study was to evaluate the hypothesis that TMJ arthrocentesis with injection of autologous micro fragmented adipose tissue leads to better clinical outcomes in terms of reducing pain and improving function compared with arthrocentesis and injection of platelets rich plasma (prp)in patients with TMJ internal derangement and osteoarthritis.

Preliminary results of this clinical trial show that the injection of micro fragmented adipose tissue can significantly improve outcomes of pain and function compared with the standard treatment and encourage to pursue research on this topic.

Further studies with a longer follow-up time are needed to evaluate the clinical stability of the achieved improvement in pain and function.

For this reason, this protocol has been designed with the aim to investigate whether injection in the TMJ of micro fragmented fat tissue can achieve the same improvements of pain and function, compare this technique with prp injection.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Anterior disc displacement with reduction (DDwR) of the temporomandibular joint (TMJ) is a prevalent condition characterized by the displacement of the articular disc during jaw movement, often leading to pain, clicking sounds, and restricted mouth opening. Traditional treatments include conservative approaches such as physical therapy, occlusal splints, and pharmacological interventions. However, for patients unresponsive to these methods, intra-articular injections of regenerative therapies like microfragmented adipose tissue (MFAT) and platelet-rich plasma (PRP) have emerged as promising alternatives.

Arthrocentesis first described by Nitzan et al. \[1.2\] is the simplest intervention on the TMJ with the aim to decrease joint pain and improve the range of motion in patients not responding to initial conservative treatment.

Arthrocentesis consists of an intraarticular lavage using 2 needles placed in the upper joint space. It is a versatile technique which can be performed under local anesthesia in an outpatient setting as well Arthrocentesis has been demonstrated to be a very effective procedure with a high success rate and a favorable benefit-cost ratio.

In addition to arthrocentesis:

Microfragmented Adipose Tissue (MFAT) Injections MFAT involves the extraction and processing of adipose tissue to create a suspension rich in mesenchymal stem cells, growth factors, and extracellular matrix components. This suspension is then injected into the affected joint to promote tissue repair and reduce inflammation.

A study published in Stem Cells Translational Medicine in 2023 evaluated the efficacy of MFAT injections in patients with knee osteoarthritis. The results demonstrated significant improvements in joint pain and functionality, with median changes in the Knee injury and Osteoarthritis Outcome Score (KOOS) Pain subscale ranging from 18.1 at week 2 to 27.8 at 1 year. These findings suggest that MFAT may be a viable alternative treatment for patients with joint conditions who fall into the orthopedic treatment gap.

While this study focused on knee osteoarthritis, the regenerative properties of MFAT suggest potential applicability to TMJ disorders. However, further research is needed to confirm its effectiveness in the TMJ context.

Platelet-Rich Plasma (PRP) Injections PRP therapy involves concentrating platelets from the patient's own blood and injecting them into the affected joint to stimulate healing.

A systematic review published in BMC Oral Health in 2024 examined the effectiveness of PRP injections for TMJ disorders. The review concluded that PRP injections, particularly when combined with arthrocentesis, were effective in reducing pain and improving mandibular function in patients with TMJ internal derangement.

Additionally, a study in the Open Journal of Stomatology in 2023 evaluated the effect of platelet-rich growth factors (PRGFs) in the treatment of TMJ disc displacement. The results indicated that PRGFs could be a possible alternative treatment for patients who did not respond to standard treatments, showing early efficacy in reducing pain and improving joint function.

Comparative Efficacy While both MFAT and PRP injections have demonstrated efficacy in treating joint disorders, direct comparative studies in the context of TMJ anterior disc displacement with reduction are limited. The existing literature primarily focuses on individual therapies rather than head-to-head comparisons. Therefore, it is challenging to definitively conclude which treatment offers superior outcomes for TMJ disorders.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

TMJ Disc Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

B) Injectable Lipogems, a form of adipose (fat) tissue-derived regenerative medicine, is an emerging treatment for a variety of musculoskeletal conditions, including TMJ disorders such as anterior disc displacement with reduction. Lipogems involves harvesting and processing a small amount of the patient's own fat tissue, then injecting it into the affected area. Here's why Lipogems is considered an important option in treating TMJ disorders with anterior disc displacement with reduction.

Lipogems contains a rich concentration of regenerative cells, such as mesenchymal stem cells (MSCs), along with growth factors, cytokines, and other bioactive molecules. These components play a crucial role in tissue regeneration, healing, and the repair of damaged structures within the TMJ, such as the articular disc, ligaments, and surrounding tissues. These growth factors can support the healing process of the damaged tissues that may be contributing to the disc displacement.
Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Caregivers Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

platelet-rich plasma

Group Type ACTIVE_COMPARATOR

platelet-rich plasma

Intervention Type OTHER

I - double-puncture arthrocentesis technique was followed, and 300 mL of Ringer's lactate solution was used to irrigate the joint space through the marked points . After arthrocentesis PRP was prepared from 5 mL of autologous venous blood sample taken from the antecubital vein. The collected blood was then transferred to a test tube containing 0.5 mL of sodium citrate (anticoagulant) (0.5 mL) and was centrifuged at a rate of 2100 rpm for 15 min. The plasma from the first harvest was fractionated by centrifugation at 3500 rpm for 10 min to prepare PRP.

microfragmented adipose tissue

Group Type EXPERIMENTAL

microfragmented adipose tissue

Intervention Type OTHER

Receive micro fragmented adipose tissue obtained from the buccal pad of fat after arthrocentessis.

* Direct access to the buccal fat pad, is found at distobuccal depth of the maxillary tuberosity.
* It may be dissected during the resection an upper mucosal incision posterior to the second molar
* After a single scissor stab through the periosteum the (BFP)extrude into the operative site.
* Closure of the flap by suitable suture.
* Collection of lipids then manually manipulated with two syringes connecting together and pushing the lipids against each other to receive the injectable amount of micro fragmented adipose tissue .
* Ready for TMJ injection.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

microfragmented adipose tissue

Receive micro fragmented adipose tissue obtained from the buccal pad of fat after arthrocentessis.

* Direct access to the buccal fat pad, is found at distobuccal depth of the maxillary tuberosity.
* It may be dissected during the resection an upper mucosal incision posterior to the second molar
* After a single scissor stab through the periosteum the (BFP)extrude into the operative site.
* Closure of the flap by suitable suture.
* Collection of lipids then manually manipulated with two syringes connecting together and pushing the lipids against each other to receive the injectable amount of micro fragmented adipose tissue .
* Ready for TMJ injection.

Intervention Type OTHER

platelet-rich plasma

I - double-puncture arthrocentesis technique was followed, and 300 mL of Ringer's lactate solution was used to irrigate the joint space through the marked points . After arthrocentesis PRP was prepared from 5 mL of autologous venous blood sample taken from the antecubital vein. The collected blood was then transferred to a test tube containing 0.5 mL of sodium citrate (anticoagulant) (0.5 mL) and was centrifuged at a rate of 2100 rpm for 15 min. The plasma from the first harvest was fractionated by centrifugation at 3500 rpm for 10 min to prepare PRP.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients should have one or more signs and symptoms of these

* Disc displacement assessed by clinical examination and MRI
* Symptoms: Patients who report typical symptoms of TMJ dysfunction, such as pain, discomfort, or clicking sounds in the joint, especially when opening or closing the mouth.
* Mouth Opening: Limited range of motion or difficulty with full mouth opening .
* Clicking: Audible clicking.
* Pain: Pain or tenderness around the TMJ, often radiating to the ear, temple, or neck.

Exclusion Criteria

* Previously diagnosed hematological and neurological conditions;

* Previous malignant head and neck neoplasms;
* Contraindication to fat harvesting.
* Uncooperative patients.
* connective tissue disorders.
* a pacemaker or any other metal prosthesis in the body.
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Cairo University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

ahmed hosni

dentist

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ahmed Hosni Ahmed Hosni Ali, bachelor's degree

Role: STUDY_DIRECTOR

Cairo University

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Ahmed Hosni ali, bachelor's degree

Role: CONTACT

01552252413 ext. 01559006602

References

Explore related publications, articles, or registry entries linked to this study.

Mittal A, Klarie SJ, Sharma S, Roy B, Paul JI, Sharma S. Efficacy of Intra-articular Platelet-rich Plasma versus Hydrocortisone with Local Anaesthetic Injection in Temporomandibular Joint Disorders - A Prospective Study. Ann Maxillofac Surg. 2024 Jul-Dec;14(2):166-170. doi: 10.4103/ams.ams_237_23. Epub 2024 Sep 11.

Reference Type BACKGROUND
PMID: 39957867 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

tmj injection

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Computer Guided Single Needle Arthrocentesis
NCT07306936 ACTIVE_NOT_RECRUITING NA